AI assistant
ERYTECH Pharma S.A. — Share Issue/Capital Change 2018
Mar 7, 2018
1295_iss_2018-03-07_69c38601-c620-44d9-b86b-b5b81f4240ff.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Monthly information related to total number of voting rights and shares composing the share capital –February 28, 2018
Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon - France
Listing markets: Euronext Paris from Euronext (Market segment B - ISIN Code: FR0011471135- Symbol : ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP) Website : www.erytech.com
| Date | Total of shares composing the share capital |
Total of brut(1) voting rights |
Total of net(2) voting rights |
|---|---|---|---|
| December 31, 2017 | 17 937 559 | 19 545 443 | 19 542 943 |
| January 1, 2018 | 17 940 035(3) | 19 543 919(3) | 19 541 419 |
| February 28, 2018 | 17 940 035 | 19 546 219 | 19 543 719 |
(1) Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
(2) Without treasury shares
(3) The number of shares and voting rights increased due to issuance of shares consequently to warrants exercises and or end of vesting periods of free shares which a Board of Director will take notice of in the future.